Tango Therapeutics, Inc.
TNGX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $58 | $39 | $58 | $70 |
| Short-Term Investments | $94 | $142 | $158 | $188 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $11 | $9 | $8 | $8 |
| Total Curr. Assets | $164 | $190 | $225 | $266 |
| Property Plant & Equip (Net) | $44 | $45 | $47 | $48 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $2 | $2 | $2 | $3 |
| Total NC Assets | $46 | $48 | $49 | $50 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $210 | $238 | $274 | $316 |
| Liabilities | – | – | – | – |
| Payables | $2 | $3 | $3 | $2 |
| Short-Term Debt | $3 | $3 | $3 | $2 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $23 | $19 | $18 |
| Other Curr. Liab. | $13 | $12 | $10 | $16 |
| Total Curr. Liab. | $18 | $40 | $36 | $38 |
| LT Debt | $32 | $32 | $34 | $34 |
| Deferred Rev, NC | $0 | $30 | $38 | $45 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $32 | $63 | $72 | $79 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $35 | $35 | $37 | $36 |
| Total Liabilities | $50 | $103 | $108 | $117 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$564 | -$580 | -$541 | -$502 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $724 | $715 | $708 | $701 |
| Total Equity | $160 | $135 | $167 | $200 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $210 | $238 | $274 | $316 |
| Net Debt | -$24 | -$4 | -$21 | -$33 |